Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating Activities:
Net Loss	$ (1,250,809)	$ (942,521)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	20,328	8,936
Common stock issued for services	122,446	78,447
Compensation expense related to grant of stock options	68,944	27,068
Amortization of debt discount	0	5,990
Amortization of operating lease right of use asset	9,645	(12,289)
(Increase) decrease in:
Accounts receivable	202,759	(214,077)
Prepaid expenses and other current assets	180,256	(308,685)
Inventory	(454,634)	(605,396)
Deposits	0	(223)
Increase (decrease) in:
Accounts payable	167,147	522,770
Accrued expenses	139,730	79,456
Convertible note payable repaid in lieu of salary - related party	0	(220,417)
Sales tax payable	(51,647)	22,218
Deferred revenue	(9,948)	5,447
Net cash used in operating activities	(855,783)	(1,553,276)
Investing Activities:
Purchases of equipment	(33,445)	(125,142)
Funding of patent costs	(22,129)	(18,370)
Net cash used in investing activities	(55,574)	(143,512)
Financing Activities:
Repayments of auto loan	0	(2,718)
Withhold shares to cover taxes for cashless stock option exercise	(46,962)	0
Proceeds from warrant exercises	2,469,544	282,350
Net cash provided by financing activities	2,422,582	279,632
Net increase (decrease) in cash	1,511,225	(1,417,156)
Cash at beginning of period	26,702,804	3,849,456
Cash at end of period	28,214,029	2,432,300
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	0	52,666
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Transfer of prepaid asset to inventory	0	72,750
Depreciation cost capitalized into inventory	$ 6,046	$ 3,705